Emerging evidence is revealing the interplay between AMR and climate change. How are they linked, and how can we address the challenge?
Read storyNovel antimicrobials are desperately needed to combat the AMR crisis, however, the clinical and preclinical pipeline for novel antimicrobials is virtually stagnant. This article will shed light on parasitic worms as an unexplored and underappreciated source of antimicrobial peptides.
Common motifs between Streptomyces and sites of spiritual healing may help with the discovery of new sites for bioprospecting. Although there may be a temptation to dismiss the spiritual nature of the healing sites, it is important that researchers begin to understand these in the appropriate cultural and spiritual context.
The deep expanse of the Earth’s mysterious marine habitat is teeming with opportunities for scientific discovery, including solutions to the world’s most pressing health crises. Among its rich biodiversity are tiny microbes with tremendous potential.
Applied Microbiology International (AMI) has urged global policymakers to strengthen the revised Global Action Plan on Antimicrobial Resistance (GAP-AMR), calling for a more inclusive, clear and equitable approach to tackling one of the world’s most urgent health challenges.
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.
Read storyScientists find that certain gut bacteria are essential for building immune defenses during infancy, pointing to new strategies for protecting children’s health. They have identified a way to preserve healthy immune development even when infants need antibiotic treatment.
Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.
Researchers have developed two methods that allow urine samples to be tested directly for antibiotic susceptibility. Because the procedures do not require standardized bacterial suspensions, the time to result is reduced by up to 24 hours compared to conventional testing.
The therapeutic potential of bacteriophages (or ‘phages’) has been widely dismissed for decades in the West, despite being regularly used to treat patients worldwide in the early and mid-20th century. In an age rife with disinformation, can the true potential of clinical phage technology be communicated to a public already uneasy about scientific intervention?
Read storyIn many developing countries, the use of antibiotics in both humans and animals is often indiscriminate and poorly regulated. Could livestock-originated probiotics be a suitable replacement?
The fight against AMR will require innovation, collaboration, and a fundamental shift in perspective – but it’s a fight we can win.
Is it acceptable to prioritize production over welfare?
Shan Goh from the University of Hertfordshire reports back on the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork held in Rennes, France, in October. Shan was supported with a Scientific Event Travel Grant awarded by AMI.
Read storyDr Kwanrawee Joy Sirikanchana outlines how her team has launched a major project to address an overlooked question: How much does aquaculture contribute to AMR in shared water systems, and what does this mean for people, animals, and wildlife living around them?
Oliver Spiller-Boulter, from Cardiff, reports back on his AMI-sponsored summer studentship which examined antimicrobial resistance (AMR) in neonatal sepsis and the use of novel bacterial screening methods.
Dr Hannah Trivett, University of Birmingham, reports back from EMBL Human Microbiome Conference held in Heidelberg, Germany, where she presented her research with the support of AMI’s Scientific Event Travel Grant.